GLP-1 Agonist (Semaglutide) Trials
Type 2 Diabetes and Obesity
Phase 3Active (Key Role in FDA-Approved Trials)
Key Facts
Indication
Type 2 Diabetes and Obesity
Phase
Phase 3
Status
Active (Key Role in FDA-Approved Trials)
About Clinical Investigation Specialists
Clinical Investigation Specialists Inc. (CIS Research) is a privately-held clinical research organization committed to delivering excellence to the global healthcare sector by making new treatment options available to patients. The company operates award-winning research centers in Gurnee, IL and Kenosha, WI, and has established a Pharmacy Fellowship Program to train the next generation of clinical research professionals. Under the leadership of Dr. Eva Agaiby, CIS Research actively conducts trials in cardiometabolic, cardiovascular, and neurological diseases, contributing to the development of groundbreaking therapies, including recent involvement in FDA-approved diabetes and weight loss trials.
View full company profile